The GW VRU Director, Dr. David Diemert, weighs in on two candidate vaccine viruses for H5N1 bird flu that could be used to make vaccines.
Bird Flu: U.S. Could Produce and Ship 100 Million Vaccine Doses Within Months
Latest News
FDA Approves Abrysvo for Adults 18-59 at Increased Risk for RSV
Mpox Vaccine Is Safe and Generates a Robust Antibody Response in Adolescents
Latest news about the results of the COVAIL trial regarding the Sanofi booster. GW participated as one of the many sites for this COVID-19 vaccine study.